Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: A WorldWide Antimalarial Resistance Network individual participant data meta-analysis
<p style="text-align:justify;"> <b>Background:</b> Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequen...
Main Author: | Price, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2019
|
Similar Items
-
Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis
by: The WorldWide Antimalarial Resistance Network Methodology Study Group
Published: (2019-07-01) -
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
Published: (2022) -
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
by: The WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group
Published: (2022-03-01) -
Optimising statistical methodologies for estimating antimalarial efficacy for uncomplicated Plasmodium falciparum malaria
by: Dahal, P
Published: (2018) -
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Senegal
by: Faye Oumar, et al.
Published: (2007-06-01)